Spyre Therapeutics, Inc.

BARCLAYS PLC SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

3/30/2026

Shares

99

Value ($000)

0

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	3/30/2026	0	0.0%	99	6/30/2023
2023 Q1	3/30/2026	0	0.0%	99	3/31/2023
2022 Q4	3/30/2026	0	0.0%	99	12/31/2022
2022 Q3	11/3/2022	0	0.0%	99	9/30/2022
2022 Q2	8/12/2022	0	0.0%	99	6/30/2022
2022 Q1	5/16/2022	16	0.0%	6,660	3/31/2022
2021 Q4	2/14/2022	233	0.0%	49,153	12/31/2021
2021 Q3	11/9/2021	131	0.0%	16,524	9/30/2021
2021 Q2	8/13/2021	40	0.0%	5,668	6/30/2021
2021 Q1	5/13/2021	301	0.0%	37,962	3/31/2021
2020 Q4	2/11/2021	116	0.0%	14,720	12/31/2020
2020 Q3	11/12/2020	139	0.0%	19,636	9/30/2020
2020 Q2	8/12/2020	213	0.0%	23,137	6/30/2020
2020 Q1	5/13/2020	41	0.0%	8,675	3/31/2020
2019 Q4	2/10/2020	202	0.0%	26,481	12/31/2019